Richard Robert E. 4
4 · Lyra Therapeutics, Inc. · Filed Jun 26, 2020
Insider Transaction Report
Form 4
Richard Robert E.
SVP of R&D
Transactions
- Award
Stock Option
2020-06-24+35,000→ 35,000 totalExercise: $12.33Exp: 2030-06-24→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 25% of the shares on June 23, 2021 and in 36 equal monthly installments thereafter.